Beijing Chest Hospital
Clinical trials sponsored by Beijing Chest Hospital, explained in plain language.
-
New hope against Drug-Resistant lung infection?
Disease control ENROLLING_BY_INVITATIONThis study looks at whether the antibiotic omadacycline can help people with a hard-to-treat lung infection caused by Mycobacterium abscessus. Researchers will review medical records of 200 patients to see how many get better or are cured. The goal is to find out which patients b…
Sponsor: Beijing Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New antibiotic shows promise against Drug-Resistant lung bug
Disease control ENROLLING_BY_INVITATIONThis study tests a new antibiotic called contezolid against a hard-to-treat lung infection caused by Mycobacterium abscessus. Twenty-four adults will take either contezolid or an older drug, linezolid, for 14 days. Researchers will measure how quickly the drug kills the bacteria …
Phase: PHASE2 • Sponsor: Beijing Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Blood tests could personalize TB dosing to boost success and cut harm
Knowledge-focused ENROLLING_BY_INVITATIONThis study is tracking over 2,200 tuberculosis patients to see how the amount of TB drugs in their blood relates to how well the treatment works and whether they have side effects. By measuring drug levels, researchers hope to find ways to adjust doses for each person, especially…
Sponsor: Beijing Chest Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC